Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAMYCIN vs RILPIVIRINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIFAMYCIN vs RILPIVIRINE: Safety Overview

Metric RIFAMYCIN RILPIVIRINE
Total FAERS Reports 106 7,049
Deaths Reported 26 196
Death Rate 24.5% 2.8%
Hospitalizations 35 593
Average Patient Age 56.1 yrs 45.8 yrs
% Female Patients 54.5% 29.5%
FDA Approval Date Nov 16, 2018 Jan 29, 2026
Manufacturer N/A Janssen Products, LP
Route N/A ORAL
Marketing Status Discontinued Prescription